Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy Cover

.blurhash-client-img { display: none !important; }

Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy

Radiology and Oncology

Volume 51 (2017): Issue 1 (March 2017)

By: Daniel Omersa, Tanja Cufer, Robert Marcun and Mitja Lainscak

Open Access

|Feb 2016

Authors

Daniel Omersa

National Institute of Public Health, Ljubljana, Slovenia

Tanja Cufer

University Clinic Golnik, Golnik, Slovenia

Faculty of Medicine, Ljubljana, Slovenia

Robert Marcun

University Clinic Golnik, Golnik, Slovenia

Mitja Lainscak

mitja.lainscak@guest.arnes.si

Faculty of Medicine, Ljubljana, Slovenia

Departments of Cardiology and Research and Education, General Hospital Celje, Celje, Slovenia

DOI: https://doi.org/10.1515/raon-2016-0037 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 15 - 22

Submitted on: Feb 9, 2016

|

Accepted on: May 8, 2016

|

Published on: Feb 7, 2016

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

cardiotoxicity,

platinum-based chemotherapy,

cardiac biomarkers

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2016 Daniel Omersa, Tanja Cufer, Robert Marcun, Mitja Lainscak, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 51 (2017): Issue 1 (March 2017)Next article